1 active not recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Active not recruiting 1 |
Follow B-cell Malignancies: new trials by email Literature Review of B-cell Malignancies trials Research Report on B-cell Malignancies
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate Long-term Safety of Zanubrutinib Regimens in Participants With B-Cell Malignancies Who Participated in BeiGene Parent Studies of Zanubrutinib Zanubrutinib, Tislelizumab - B-cell Malignancies | Phase 3 | Active not recruiting | BeOne Medicines | 955 | 2020-01-16 | 2026-08-28 |
tislelizumab (1) · zanubrutinib (1)
BeOne Medicines (1)
Australia (1) · China (1) · Czechia (1) · France (1) · Germany (1) · Greece (1) · Italy (1) · Japan (1) · Netherlands (1) · New Zealand (1) · Poland (1) · South Korea (1) · Spain (1) · Sweden (1) · Taiwan (1)